+86 189 1304 2753 product@eynoslifescience.com

Technical notes

Validation data

Purity and recovery from real separations, reported with the sample, the gate and the caveats. The Chinese editions carry the full flow plots; English editions are being published step by step.

Literature

Our RV02-20 retroviral vector is cited in the Methods of a 2026 Nature Communications paper on DNMT3A-driven immune evasion in colorectal cancer (Zhao J. et al., Nat Commun 2026;17:10729), where it was used to transduce human CD8⁺ T cells at MOI 5.

From November 2026 every new technical article is published in both Chinese and English. Older Chinese articles remain available on the Chinese site; translations are released progressively.

Looking for a protocol that is not listed yet?

Tell us your cell type, sample source and downstream assay — we will suggest an isolation route, a culture condition and the matching catalogue numbers.